Most discussions cite precise data from the OMEMI trial, such as its lack of benefit in reducing cardiovascular events and increased risk of atrial fibrillation, with tone reflecting scientific skepticism. The tone balances technical details with expressions of disappointment, which highlights a measured yet engaged exploration of the study's implications, emphasizing the evidence against omega-3 supplements' efficacy in this context.
AgreementLow agreement
Most discussions highlight that the study found no significant benefit of omega-3 supplements for elderly post-MI patients, showing some skepticism about their effectiveness.
InterestModerate interest
Discussions demonstrate moderate interest, especially among those in the medical community referencing detailed trial data and study outcomes.
EngagementModerate engagement
Participants refer to specific results, HR values, and studies, indicating a moderate depth of engagement with scientific details.
ImpactLow impact
Posts suggest limited impact of the findings on current practices, emphasizing that omega-3 supplements did not demonstrate a clear benefit and therefore may not influence treatment guidelines.
Top posts
Most liked on X and Bluesky
PP
Peder L. Myhre MD, PhD
@pmyhre · X
Proud to share the primary results from #OMEMI: RCT of 1.8g EPA/DHA vs placebo in elderly post-MI patients w/2y f-u.
NO diff. in MACE: HR 1.07, p=0.62
Incr. risk of new-onset AF: HR 2.84, p=0.056
Presented as LBCT at #AHA20 with simpub in @CircAHA
https://t.co/puKbkNGa8q
(1/5) https://t.co/VgxkfAoAG5
Nov 15, 2020 · 54 likes · 10 shares · 1,501 followersView post →
C
Circulation
@CircAHA · X
OMEMI- 1.8g/day of OM3FA did not reduce CVD in elderly with AMI https://t.co/8ObG79ESdS #CircAHA20 #AHA20 #AHAJournals @AAKalstad @pmyhre @Oslounivsykehus @UniOslo https://t.co/JV4RExu8fr
Nov 15, 2020 · 23 likes · 12 shares · 77,815 followersView post →
DR
Dr. Eddie Ramirez
@EddieRDMD · X
Low-dose OMEGA-3 fatty acids offered no cardiovascular benefit over CORN OIL placebo in two randomized trials of high-risk patients
JAMA: https://t.co/qw8t5ooTsI
Circulation: https://t.co/bUZ4vxoh4U
Press: https://t.co/FSJdoBFS58 @_atanas_
Nov 23, 2020 · 21 likes · 6 shares · 4,916 followersView post →
DP
Dr. Purvi Parwani
@purviparwani · X
#OMEMI
#AHA20
➡️PUFA VS placebo in elderly pts with AMI
➡️ 930 g EPA+660 g DHA
N=1027, Follow up= 24 months, Mean Age= 74 years
➡️Primary outcome = 21.0% of the PUFA group vs 19.8% in Placebo
⬆️in AF with PUFA
NO BENEFIT
NOT ALL PUFA SAME
https://t.co/Ez0q0uH28G https://t.co/olQsOdS7kQ
Nov 15, 2020 · 10 likes · 4 shares · 39,984 followersView post →
IM
Ivan Mendoza
@mencardio · X
Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction:No Benefit @ivanovich13 @torresviera @SIAC_cardio @CardiologiaSVC #AHA20 @adribaran @igormorr @gonzaeperez https://t.co/22Jo84HEb4
Nov 15, 2020 · 9 likes · 7 shares · 7,235 followersView post →
C
Circulation
@CircAHA · X
OMEMI: In RCT of elderly patients with a recent acute myocardial infarction, n-3 fatty acid supplementation did not reduce clinical events. Read more: https://t.co/nGs5DGGtmT #AHAJournals @Oslounivsykehus @UniOslo @pmyhre @AAKalstad https://t.co/I3Gr89ztyj
Feb 11, 2021 · 7 likes · 3 shares · 77,815 followersView post →
This video discusses upcoming trends in cardiology research and scientific developments anticipated by 2026, including advances in treatments and clinical trials, with a focus on cardioprotective strategies and elderly…
Dr Gillett and Nurse Practitioner James OHara discuss potential risks associated with omega-3s, including findings from recent studies on their impact on atrial fibrillation and blood viscosity, providing a…
@neeche41 @LovingGeneva @skathire @AstraZeneca Here are some reference numbers
https://t.co/ng7HJu6MUi
GISSI-P was terminated. The dosage was also <1g/day. The closest to the same setup was the OMEMI study which showed no CV benefit.
https://t.co/Ks5g7T2Fo8
The conclusion was dosage related benefit
Aug 22, 2022 · 1 like · 1 share · 241 followersView post →
IK
Italo Kumamoto
@fikkumamoto · X
RT @pmyhre: Proud to share the primary results from #OMEMI: RCT of 1.8g EPA/DHA vs placebo in elderly post-MI patients w/2y f-u.
NO diff.…
Mar 4, 2022 · 10 shares · 8,783 followersView post →
RCT: Omega-3 supplements do not reduce cardiovascular events in elderly patients after myocardial infarction – via @CircAHA
https://t.co/3va2ufKf3Z
Commentary: https://t.co/41fbin4pyy
Mar 3, 2021 · 2 likes · 29,263 followersView post →
AB
Altamiro Bottino
@BottinoAltamiro · X
Omega-3s did not reduce cardiac events in recent heart attack survivors
https://t.co/Smig7eKOs9
https://t.co/l2NSGJOKgI https://t.co/QB5neQ6EEL
OMEMI: In RCT of elderly patients with a recent acute myocardial infarction, n-3 fatty acid supplementation did not reduce clinical events. Read more: https://t.co/nGs5DGGtmT #AHAJournals @Oslounivsykehus @UniOslo @pmyhre @AAKalstad https://t.co/I3Gr89ztyj
Feb 11, 2021 · 7 likes · 3 shares · 77,815 followersView post →
SL
Sergio Lavandero
@sergiolavandero · X
Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction https://t.co/ulGcrMNK2h
Feb 9, 2021 · 3 likes · 1,481 followersView post →
TL
the paper link
@the_paper_link · X
Trend up+7: **Kalstad AA** et al (Circulation) __Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized Controlled Trial__
https://t.co/wQMgXFv3ZB
Nov 20, 2020 · 1 like · 3,998 followersView post →
DL
Derek Leong
@Derek_Leong_RPh · X
OMEMI trial: In Pts. 70-82 y.o., recent MI (2-8 weeks post), n-3 PUFA (930 mg EPA/660 mg DHA) 1.8 g/d did not ⬇️MACE vs. corn oil at 2 years. Non-significant ⬆️new-onset AFib with n-3 PUFA. No difference in major bleeding.
https://t.co/0eu3Ypszl1 https://t.co/gIsXA6nRfW
Nov 18, 2020 · 6 likes · 1,550 followersView post →
C
Carmelo
@carmelprzrz · X
RT @rincondesisifo: (Circulation) El suplemento con ácidos grasos omega 3 en ancianos postIAM no mejora los resultados clínicos https://t.c…
Nov 18, 2020 · 2 shares · 447 followersView post →
TL
the paper link
@the_paper_link · X
RT @the_paper_link: Trend new: **Kalstad AA** et al (Circulation) __Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocard…
RT @rincondesisifo: (Circulation) El suplemento con ácidos grasos omega 3 en ancianos postIAM no mejora los resultados clínicos https://t.c…
Nov 18, 2020 · 2 shares · 1,996 followersView post →
R
rincondesisifo
@rincondesisifo · X
(Circulation) El suplemento con ácidos grasos omega 3 en ancianos postIAM no mejora los resultados clínicos https://t.co/ixPW9jjjzk ECA https://t.co/FGBQdZjTeE
Nov 18, 2020 · 1 like · 2 shares · 8,422 followersView post →
TL
the paper link
@the_paper_link · X
Trend new: **Kalstad AA** et al (Circulation) __Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized Controlled Trial__
https://t.co/wQMgXFv3ZB
Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized Controlled Trial https://t.co/Wm52w2rPdk
CONCLUSIONS: We could not detect reduction in clinical events in our elderly patients with a recent AMI, treated with 1.8 g n-3 FAs for 2 y
RT @mencardio: Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction:No Benefit @ivanovich13 @torresvier…
Nov 16, 2020 · 7 shares · 2,473 followersView post →
SN
Science news
@UpdateonScience · X
https://t.co/PN2GJOSYPJ When compared to a placebo, an omega-3 fatty acids supplement in addition to statin therapy and/or a blood thinner did not reduce the number of cardiac events in a study of more than 1,000 patients in Norway. The rate of cardiac events was about 20% in b… https://t.co/bqLb5lY0Zq
RT @pmyhre: Proud to share the primary results from #OMEMI: RCT of 1.8g EPA/DHA vs placebo in elderly post-MI patients w/2y f-u.
NO diff.…
Nov 16, 2020 · 10 shares · 180 followersView post →
K
Kamol
@KamolMU · X
RT @ValleAlfonso: Effects of n-3 Fatty Acid Supplements in Elderly Patients (
Nov 16, 2020 · 6 shares · 100 followersView post →
SL
Sergio Lavandero
@sergiolavandero · X
Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized Controlled Trial | Circulation https://t.co/pjPt61vc3j
Nov 16, 2020 · 1 like · 1,481 followersView post →
JN
Juan NAVARRO
@jnavarrosimon · X
RT @ValleAlfonso: Effects of n-3 Fatty Acid Supplements in Elderly Patients (
Nov 16, 2020 · 6 shares · 746 followersView post →
RT @pmyhre: Proud to share the primary results from #OMEMI: RCT of 1.8g EPA/DHA vs placebo in elderly post-MI patients w/2y f-u.
NO diff.…
Nov 15, 2020 · 10 shares · 100 followersView post →
ST
SALUD TOTAL
@MiSaludTotal · X
RT @mencardio: Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction:No Benefit @ivanovich13 @torresvier…
Nov 15, 2020 · 7 shares · 1,011 followersView post →
YM
yolimar meza
@meza0208 · X
RT @mencardio: Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction:No Benefit @ivanovich13 @torresvier…
Nov 15, 2020 · 7 shares · 723 followersView post →
F
FUNDAPROCECA
@FUNDAPROCECA · X
RT @mencardio: Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction:No Benefit @ivanovich13 @torresvier…
Nov 15, 2020 · 7 shares · 1,059 followersView post →
IM
Igor Morr
@igormorr · X
RT @mencardio: Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction:No Benefit @ivanovich13 @torresvier…
Nov 15, 2020 · 7 shares · 3,913 followersView post →
IM
Ivan Mendoza
@mencardio · X
Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction:No Benefit @ivanovich13 @torresviera @SIAC_cardio @CardiologiaSVC #AHA20 @adribaran @igormorr @gonzaeperez https://t.co/22Jo84HEb4
Nov 15, 2020 · 9 likes · 7 shares · 7,235 followersView post →
岩老
岩手医科大学 脳神経内科・老年科
@IwateNeurol · X
RT @CircAHA: OMEMI- 1.8g/day of OM3FA did not reduce CVD in elderly with AMI https://t.co/8ObG79ESdS #CircAHA20 #AHA20 #AHAJournals @AAKal…
Nov 15, 2020 · 12 shares · 1,029 followersView post →
AV
Alfonso Valle
@ValleAlfonso · X
Nov 15, 2020 · 1 like · 1 share · 21,717 followersView post →
PP
Peder L. Myhre MD, PhD
@pmyhre · X
RT @purviparwani: #OMEMI
#AHA20
➡️PUFA VS placebo in elderly pts with AMI
➡️ 930 g EPA+660 g DHA
N=1027, Follow up= 24 months, Mean Age=…
Nov 15, 2020 · 4 shares · 1,501 followersView post →
BA
Benoit Arsenault
@ArsenaultBenoit · X
RT @purviparwani: #OMEMI
#AHA20
➡️PUFA VS placebo in elderly pts with AMI
➡️ 930 g EPA+660 g DHA
N=1027, Follow up= 24 months, Mean Age=…
Nov 15, 2020 · 4 shares · 5,713 followersView post →
RF
Rosa Fernandez
@MAROSFO · X
RT @JTLLERGO: ⚠️Effects of n-3 Fatty Acid Supplements in Elderly Patients (70-82 y) after Myocardial Infarction:
Nov 15, 2020 · 4 shares · 3,332 followersView post →
RP
Román Freixa Pamias
@rfreixap · X
RT @JTLLERGO: ⚠️Effects of n-3 Fatty Acid Supplements in Elderly Patients (70-82 y) after Myocardial Infarction:
Nov 15, 2020 · 4 shares · 1,023 followersView post →
DP
Dr. Purvi Parwani
@purviparwani · X
#OMEMI
#AHA20
➡️PUFA VS placebo in elderly pts with AMI
➡️ 930 g EPA+660 g DHA
N=1027, Follow up= 24 months, Mean Age= 74 years
➡️Primary outcome = 21.0% of the PUFA group vs 19.8% in Placebo
⬆️in AF with PUFA
NO BENEFIT
NOT ALL PUFA SAME
https://t.co/Ez0q0uH28G https://t.co/olQsOdS7kQ
Nov 15, 2020 · 10 likes · 4 shares · 39,984 followersView post →
RV
Raul Villar
@DrRaulvillar · X
RT @pmyhre: Proud to share the primary results from #OMEMI: RCT of 1.8g EPA/DHA vs placebo in elderly post-MI patients w/2y f-u.
NO diff.…
Nov 15, 2020 · 10 shares · 412 followersView post →
ES
Else C. Sandset
@ECSandset · X
RT @CircAHA: OMEMI- 1.8g/day of OM3FA did not reduce CVD in elderly with AMI https://t.co/8ObG79ESdS #CircAHA20 #AHA20 #AHAJournals @AAKal…
Nov 15, 2020 · 12 shares · 3,048 followersView post →
DD
Daniel J Drucker
@DanielJDrucker · X
The Monkees 1967 "I thought love was only true in fairy tales...Disappointment haunted all of my dreams" Clinging to REDUCE-IT and Icosapent Ethyl? No #CVD benefit for .8 g n-3 PUFA (930 mg EPA and 660 mg DHA) in 72-80 yo PPL with recent acute MI @CircAHA https://t.co/mVyEKjimJz https://t.co/Ujmelx8Nsv
Nov 15, 2020 · 1 like · 35,079 followersView post →
С
СГАМ
@CGAM2016 · X
RT @CircAHA: OMEMI- 1.8g/day of OM3FA did not reduce CVD in elderly with AMI https://t.co/8ObG79ESdS #CircAHA20 #AHA20 #AHAJournals @AAKal…
Nov 15, 2020 · 12 shares · 234 followersView post →
ÁM
Álvaro Melgar
@alvaritomelgar4 · X
RT @JTLLERGO: ⚠️Effects of n-3 Fatty Acid Supplements in Elderly Patients (70-82 y) after Myocardial Infarction:
Nov 15, 2020 · 4 shares · 221 followersView post →
DD
Dr Gomez Doblas
@DrDoblas · X
RT @JTLLERGO: ⚠️Effects of n-3 Fatty Acid Supplements in Elderly Patients (70-82 y) after Myocardial Infarction:
Nov 15, 2020 · 4 shares · 2,986 followersView post →
JT
Javier Torres
@JTLLERGO · X
⚠️Effects of n-3 Fatty Acid Supplements in Elderly Patients (70-82 y) after Myocardial Infarction:
Nov 15, 2020 · 4 likes · 4 shares · 5,189 followersView post →
JS
Juan Senior
@jsenior64 · X
Effects of n-3 Fatty Acid Supplements in Elderly Patients after Myocardial Infarction: A Randomized Controlled Trial https://t.co/DLzJt4EZWL
RT @pmyhre: Proud to share the primary results from #OMEMI: RCT of 1.8g EPA/DHA vs placebo in elderly post-MI patients w/2y f-u.
NO diff.…
Nov 15, 2020 · 10 shares · 24 followersView post →
MV
Muthu Vaduganathan
@mvaduganathan · X
RT @pmyhre: Proud to share the primary results from #OMEMI: RCT of 1.8g EPA/DHA vs placebo in elderly post-MI patients w/2y f-u.
NO diff.…
Nov 15, 2020 · 10 shares · 9,318 followersView post →
DS
Dr. Sheila Sahni
@DrSheilaSahni · X
RT @pmyhre: Proud to share the primary results from #OMEMI: RCT of 1.8g EPA/DHA vs placebo in elderly post-MI patients w/2y f-u.
NO diff.…
Nov 15, 2020 · 10 shares · 18,560 followersView post →
DB
Dr. Deepak L. Bhatt
@DLBHATTMD · X
RT @pmyhre: Proud to share the primary results from #OMEMI: RCT of 1.8g EPA/DHA vs placebo in elderly post-MI patients w/2y f-u.
NO diff.…
Nov 15, 2020 · 10 shares · 40,631 followersView post →
JY
joshua #2023yearofrebuilding
@joshfoo · X
RT @pmyhre: Proud to share the primary results from #OMEMI: RCT of 1.8g EPA/DHA vs placebo in elderly post-MI patients w/2y f-u.
NO diff.…
Nov 15, 2020 · 10 shares · 136 followersView post →
PP
Peder L. Myhre MD, PhD
@pmyhre · X
RT @CircAHA: OMEMI- 1.8g/day of OM3FA did not reduce CVD in elderly with AMI https://t.co/8ObG79ESdS #CircAHA20 #AHA20 #AHAJournals @AAKal…
Nov 15, 2020 · 12 shares · 1,501 followersView post →
PP
Peder L. Myhre MD, PhD
@pmyhre · X
Proud to share the primary results from #OMEMI: RCT of 1.8g EPA/DHA vs placebo in elderly post-MI patients w/2y f-u.
NO diff. in MACE: HR 1.07, p=0.62
Incr. risk of new-onset AF: HR 2.84, p=0.056
Presented as LBCT at #AHA20 with simpub in @CircAHA
https://t.co/puKbkNGa8q
(1/5) https://t.co/VgxkfAoAG5
Nov 15, 2020 · 54 likes · 10 shares · 1,501 followersView post →
AF
Adam Potter, MD, PhD, FACC
@AdamPotterMDPhD · X
RT @CircAHA: OMEMI- 1.8g/day of OM3FA did not reduce CVD in elderly with AMI https://t.co/8ObG79ESdS #CircAHA20 #AHA20 #AHAJournals @AAKal…
Nov 15, 2020 · 12 shares · 446 followersView post →
KM
Kevin Tijerina Flores, MD
@kevin_tijerina · X
RT @CircAHA: OMEMI- 1.8g/day of OM3FA did not reduce CVD in elderly with AMI https://t.co/8ObG79ESdS #CircAHA20 #AHA20 #AHAJournals @AAKal…
Nov 15, 2020 · 12 shares · 403 followersView post →
PS
Ph.Gabriel Steg
@gabrielsteg · X
RT @CircAHA: OMEMI- 1.8g/day of OM3FA did not reduce CVD in elderly with AMI https://t.co/8ObG79ESdS #CircAHA20 #AHA20 #AHAJournals @AAKal…
Nov 15, 2020 · 12 shares · 2,943 followersView post →
H
hgoodell
@hgoodell · X
RT @CircAHA: OMEMI- 1.8g/day of OM3FA did not reduce CVD in elderly with AMI https://t.co/8ObG79ESdS #CircAHA20 #AHA20 #AHAJournals @AAKal…
Nov 15, 2020 · 12 shares · 188 followersView post →
C
Circulation
@CircAHA · X
OMEMI- 1.8g/day of OM3FA did not reduce CVD in elderly with AMI https://t.co/8ObG79ESdS #CircAHA20 #AHA20 #AHAJournals @AAKalstad @pmyhre @Oslounivsykehus @UniOslo https://t.co/JV4RExu8fr
Nov 15, 2020 · 23 likes · 12 shares · 77,815 followersView post →